VHCP Management II, LLC's Net Worth

$618 Million

Estimate Recalculated Feb 22, 2024 08:18PM EST

Who is VHCP Management II, LLC?

VHCP Management II, LLC has an estimated net worth of $618 Million. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Shockwave Medical, Inc., KalVista Pharmaceuticals, Inc., Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., ARCA biopharma, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and Avalanche Biotechnologies, Inc..

SEC CIK

VHCP Management II, LLC's CIK is 0001602263

Past Insider Trading and Trends

2022 was VHCP Management II, LLC's most active year for acquiring shares with 46 total transactions. VHCP Management II, LLC's most active month to acquire stocks was the month of May. 2019 was VHCP Management II, LLC's most active year for disposing of shares, totalling 4 transactions. VHCP Management II, LLC's most active month to dispose stocks was the month of September. 2019 saw VHCP Management II, LLC paying a total of $13,899,999.90 for 4,786,899 shares, this is the most they've acquired in one year. In 2019 VHCP Management II, LLC cashed out on 1,593,847 shares for a total of $14,899,957.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CONSTELLATION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.06%
400K
$34.50
$13,800,000.00
4.02M
Dec 13
Form 3
0
0
No matching records found

Shockwave Medical, Inc. (SWAV) Snapshot price: $236.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.12M
2.12M
Mar 11
Form 3
0
0
No matching records found

KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-24.46%
-500.00K
$28.75
-$14,375,000.00
1.54M
Mar 18
Form 3
0
0
No matching records found

Altimmune, Inc. (ALT) Snapshot price: $10.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.22%
-1.00M
3.5M
Feb 25
Form 4
+50.00%
1.5M
$7.54
$11,310,000.00
4.5M
Jun 15
Form 4
+76.85%
1.3M
$8.74
$11,395,493.13
3M
May 26 - May 28
Form 3
0
0
No matching records found

Unum Therapeutics Inc. (COGT) Snapshot price: $6.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.55%
451K
$2.52
$1,137,120.00
4.36M
Aug 14 - Aug 18
Form 3
0
0
No matching records found